Samer Al Hadidi/UT Southwestern Simmons Cancer Center's LinkedIn
Mar 20, 2026, 16:22
Welcoming Samer Al Hadidi to the Blood Cancers Team – UT Southwestern Simmons Cancer Center
UT Southwestern Simmons Cancer Center shared a post on LinkedIn:
”Please join us in welcoming Samer Al Hadidi, M.D., to our blood cancers team.
He specializes in hematology and oncology, with an emphasis on plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.
Dr. Al Hadidi is the Clinical Director of the Amyloidosis Program at UT Southwestern.
He also serves as Leader of the Fellows’ Plasma Cell Disorders Clinic.
He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.
Learn more about Dr. Al Hadidi.”
Stay updated with Hemostasis Today.
-
Mar 20, 2026, 16:21Maxime Dely: The Lifesaving Power of Plasma Donations
-
Mar 20, 2026, 16:20Yves Bikorimana: Hemolysis – Why It Ruins Laboratory Results
-
Mar 20, 2026, 16:19Simon Senanu: G6PD Deficiency Testing – What the Lab Must Get Right
-
Mar 20, 2026, 16:18Khaled Elshazly: Can We Stop Chemotherapy-Induced Thrombocytopenia from Delaying Treatment?
-
Mar 20, 2026, 15:50Rithwic Mani: Platelet-to-Lymphocyte Ratio as A Simple and Cost-Effective Prognostic Biomarker in Stroke
-
Mar 20, 2026, 15:46Umberto Pensato: Presenting ESCAPE-MeVO Trial’s Practice-Changing Results at ESOC 2026
-
Mar 20, 2026, 15:42Varun Bafna: The Power of Extended Half-Life Factor IX in Enabling Safe Major Surgeries
-
Mar 20, 2026, 15:31Stuart Allan: An Important Translational Project In Relation to Acute Stroke Treatment
-
Mar 20, 2026, 15:30Giordano Botta: A Single Measurement in Midlife Can Reveal Future Heart Attack Risk